From basics to clinical: A comprehensive review on spinal cord injury

@article{Silva2014FromBT,
  title={From basics to clinical: A comprehensive review on spinal cord injury},
  author={Nuno A Silva and Nuno Sousa and Rui L Reis and Ant{\'o}nio J Salgado},
  journal={Progress in Neurobiology},
  year={2014},
  volume={114},
  pages={25-57}
}
Spinal cord injury (SCI) is a devastating neurological disorder that affects thousands of individuals each year. Over the past decades an enormous progress has been made in our understanding of the molecular and cellular events generated by SCI, providing insights into crucial mechanisms that contribute to tissue damage and regenerative failure of injured neurons. Current treatment options for SCI include the use of high dose methylprednisolone, surgical interventions to stabilize and… Expand

Paper Mentions

Current Status of Spinal Cord Regenerative Therapies: A Review
TLDR
This review discusses the present status of various cell-based therapies, which are being used for treating SCI, and the stem cell–based therapy has been proposed as a promising treatment strategy for SCI. Expand
Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials
TLDR
An overview of clinical trials, recorded in clinical trial.gov during 2005–2019, aimed to evaluate the use of stem cell-based therapy in SCI, show the safety and efficacy of stemcell therapy in patients with SCI. Expand
Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials
TLDR
This review digs into the possibility of cell treatment to improve medical chances in SCI repair, discussing the development of biomaterials aiming to promote in situ cell delivery. Expand
Neuroprotection in the injured spinal cord
TLDR
This chapter will focus on new neuroprotective therapies employed in the acute phase of the SCI, a complex and dynamic set of secondary events such as vascular disruption, ionic imbalance, excitotoxicity, and exacerbated inflammatory responses. Expand
Cell Therapeutic Strategies for Spinal Cord Injury.
TLDR
This review of cell therapeutics in SCI provides a systematic review of combinatory therapeutics of SCI and helps the realization of regeneration of spinal cord in the future. Expand
Recent Advances in the Regenerative Approaches for Traumatic Spinal Cord Injury: Materials Perspective.
TLDR
The regenerative approach using nanofibrous scaffolds is discussed with a focus on their fabrication methods and their properties that define their functionality performed to heal the neural tissue efficiently. Expand
Cell therapy for the treatment of spinal cord injury with focus on stem cells: A review
TLDR
A number of different cell therapies have been evaluated in both pre-clinical and clinical trials and here a review of these studies that evaluated the following types of cell therapies discusses the advantages and disadvantages of each cell type and their specific role in functional improvement. Expand
Neuroregenerative-Rehabilitative Therapy for Spinal Cord Injury
TLDR
Different types of cells available, routes of administration available to transplant these cells, dosages of cell and optimum time after injury at which cells should be transplanted based on world-wide literature are discussed. Expand
Stem cells for spinal cord injuries bearing translational potential
TLDR
Stem cells are certainly not to be considered the panacea for neural repair but they seem to be the source of some of the most promising and clinical translatable cell-based therapies that could help solving impactful problems on neural repair. Expand
Investigating local circuit function following spinal cord injury and cell transplant therapy
TLDR
An electrophysiological approach was used to directly assess functional changes in spinal cord circuits following a contusion SCI and the use of human embryonic stem cell derived mesenchymal stem cells (hESC-MSCs) as a potential therapy for spinal cord injury was investigated. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 534 REFERENCES
Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials
TLDR
The field of regenerative neuroscience should not be stalled at the animal model stage, but instead the clinical trials need to be focused, safe, and ethical, backed up by a robust, translationally relevant preclinical research strategy. Expand
Basic advances and new avenues in therapy of spinal cord injury.
TLDR
Research aims to define the temporal windows of opportunity for interventions, test the safety and efficacy of delivery systems of agents and cells, and provide a better understanding of the cascades of gene expression and cell interactions both acutely and chronically after injury. Expand
Biology of neurological recovery and functional restoration after spinal cord injury.
TLDR
An examination of the anatomic basis of recovery indicates that there is a potential for both root and cord recovery, with the latter involving recovery of both gray and white matter of the cord. Expand
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.
TLDR
This article systematically reviews the available pre-clinical research on neuroprotective therapies that are administered in a non-invasive manner for acute SCI and highlights the extent of investigation that has occurred, and points out gaps in knowledge that would be potentially valuable prior to human translation. Expand
An overview of tissue engineering approaches for management of spinal cord injuries
TLDR
The recent developments for therapeutic delivery of stem and non-stem cells to the site of injury, and application of cell-free and cell-seeded natural and synthetic scaffolds have been reviewed. Expand
A systematic review of cellular transplantation therapies for spinal cord injury.
TLDR
The systematic review makes it very apparent that cells derived from rodent sources have been the most extensively studied, while only 19 studies reported the transplantation of human cells, nine of which utilized bone-marrow stromal cells. Expand
Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects.
TLDR
It is the hypothesis that early treatment of these microcirculatory changes and neurogenic shock can lead to improved recovery after A.S.C.I.I, and that these local and systemic vascular effects are principal causes of the secondary injury leading to posttraumatic ischemia and infarction of the spinal cord after a primary injury. Expand
Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury
  • B. Kwon, J. Liu, +4 authors W. Tetzlaff
  • Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
It is found that rubrospinal neurons do not die after axotomy but, rather, they undergo massive atrophy that can be reversed by applying brain-derived neurotrophic factor to the cell bodies in the midbrain. Expand
Autologous Bone Marrow Transplantation in Patients with Subacute and Chronic Spinal Cord Injury
TLDR
This case study shows that the implantation of autologous bone marrow cells appears to be safe, as there have been no complications following implantation to date, but longer follow-ups are required to determine that implantation is definitively safe. Expand
Clinical Outcomes Using Modest Intravascular Hypothermia After Acute Cervical Spinal Cord Injury
TLDR
This study is the first phase 1 clinical trial on the safety and outcome with the use of endovascular hypothermia in the treatment of acute cervical SCI, and complication rates were similar to those of normothermic patients. Expand
...
1
2
3
4
5
...